Previous Article | Next Article ![]()
Journal of Bacteriology, March 2008, p. 1575-1583, Vol. 190, No. 5
0021-9193/08/$08.00+0 doi:10.1128/JB.01530-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Christine Florizone,
Lindsay D. Eltis, and
William W. Mohn*
Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Received 21 September 2007/ Accepted 10 December 2007
|
|
|---|
|
|
|---|
Cytochromes P450 (P450s) are involved in both biosynthesis and biodegradation of terpenoids. All terpenoids are synthesized from five-carbon precursors via a limited range of modifications (11, 33). Particular terpenoids require further modifications involving cyclization and other changes to the C skeleton (21). P450-catalyzed monooxidations are commonly employed to effect stereospecific and regiospecific addition of O-containing functional groups or to otherwise modify the C skeleton (14, 18, 32). Microorganisms and animals employ P450s to transform terpenoids, mainly to reduce the compounds' toxicity, to increase their solubility, or to exploit them as growth substrates.
There is limited evidence for the involvement of P450s in the microbial catabolism of resin acids, a class of diterpenoids synthesized mainly by trees for defense against insects and microorganisms. Because of their abundance in wood and their toxicity to fish, resin acids are important pollutants resulting from pulp and paper production (1). A wide range of bacteria are known to grow on abietane resin acids (26, 42), and recent studies have provided evidence for the involvement of P450s in bacterial catabolism of these compounds. Knockout mutagenesis in Pseudomonas diterpeniphila A19-6a indicated that the P450 TdtD (CYP226A3) is involved in, but is not essential for, catabolism of dehydroabietic acid (DhA) and abietic acid (AbA) (27). Knockout mutagenesis of Pseudomonas abietaniphila BKME-9 revealed that a TdtD homolog, DitQ, is involved in, but is not essential for, catabolism of DhA and palustric acid (PaA) but is not involved in catabolism of AbA (39). Metabolites from the BKME-9 ditQ disruption mutant and a binding assay with heterologously expressed DitQ suggested that this enzyme catalyzes hydroxylation of C-7 of DhA, but there is no direct experimental evidence for this reaction.
Burkholderia xenovorans LB400 is a member of a widespread group of soil bacteria frequently associated with plants. Recent investigation of LB400 identified a large cluster of abietane catabolic genes and suggested that bacteria may employ multiple P450s to degrade the diterpenoids (38). The LB400 gene cluster encodes two homologs of DitQBKME-9: DitQLB400 (CYP226A1) and DitU (CYP226A2). All three P450s share greater than 60% amino acid identity. This is a very high level of identity for this class of enzymes, as homologous P450s commonly share only 40% identity. The possible presence of functional P450 homologs with complementary activities may explain how the P450 knockout strains described above retained a capacity for reduced growth on abietanes. However, transcriptomic analysis of LB400 indicated that ditQ, but not ditU, was up-regulated during growth of LB400 on DhA (38). Thus, the patterns of expression and substrate specificities of various P450s likely dictate distinct roles for the enzymes in abietane metabolism, and these roles remain to be elucidated. All of the P450s implicated in abietane metabolism represent a distinct subfamily, the CYP226A subfamily. This subfamily is in the broader CYP226 family, for which the only published information is from the studies of TdtD (27) and DitQBKME-9 (39) mentioned above.
Here we describe the first proteomic investigation of microbial catabolism of abietane diterpenoids, which was aimed at clarifying the roles of P450s in the initial catabolic steps. Two-dimensional gel-based proteomic analysis of LB400 grown on DhA or on AbA revealed differential expression of the P450s DitQ and DitU. Further analysis involved characterization of LB400 ditQ and ditU disruption mutants, as well as expression of each P450 in Escherichia coli, followed by substrate-binding and activity assays of the expressed enzymes. This study provides the first conclusive evidence that two P450s have distinct functions in abietane diterpenoid catabolism and the first demonstration of a catalytic activity of a CYP226 family member.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids used in this study
|
Gene replacement. The gene encoding DitQ and the gene encoding DitU were disrupted by replacement as previously described (38). The primers and plasmids used are listed in Tables 1 and 2. The knockouts were confirmed by PCR using primers XylE5906R and HISLEFT5906 (for DitQKO) and HISLEFT5938 and HISRIGHT5938 (for DitUKO). Amplicons generated from both DitQKO and DitUKO were sequenced and were found to contain the expected product.
|
View this table: [in a new window] |
TABLE 2. Oligonucleotide primers used in PCR
|
Proteomic analyses. Cell extracts were prepared, and the cytosolic proteome was resolved using two-dimensional gel electrophoresis essentially as described previously (10, 30). Proteins were separated in the first dimension by isoelectric focusing using 24-cm, nonlinear IPG strips with a pH 3 to 7 gradient and in the second dimension using 12% sodium dodecyl sulfate-polyacrylamide gels and the ETTAN DALTtwelve system (GE Healthcare). Gels were stained using Sypro Ruby and were digitally imaged using a Typhoon 9400 (GE Healthcare). Protein spot detection and pattern matching were performed using Progenesis workstation software (Nonlinear Dynamics, Durham, NC), and then the results were verified manually. The patterns for each growth condition were based on gels from three independent cultures. The signal intensity of each spot was normalized using the total signal intensity detected on a gel. Only spots with a minimum normalized volume of 0.002 or more were analyzed further. Experimental molecular mass and isoelectric point values were assigned using the Progenesis calibration algorithm. Theoretical molecular mass and isoelectric point values were predicted based on protein sequences using the Expasy pI/Mw tool, available at http://ca.expasy.org/tools/pi_tool.html. Protein spots of interest were identified using a Voyager DESTR matrix-assisted laser desorption ionization-time of flight mass spectrometer (Applied Biosystems, Foster City, CA) based on peptide mass fingerprint analysis combined with the MASCOT search engine (www.matrixscience.com) and the LB400 protein database generated at the Proteomics Centre, University of Victoria. The proteins identified fulfilled four criteria: the MASCOT search score was greater than 52, a minimum of six peptides were matched, the protein sequence coverage was at least 20%, and the predicted mass and pI values were consistent with the experimentally determined values.
Substrate binding.
Cultures of E. coli DH5
containing pEX5938, pEX5906, or pEX18Ap were prepared and analyzed as described previously (39), with the following exception. Instead of a French press, two passes through an Emulsiflex C-5 cell disrupter operated at a homogenizing pressure of 15,000 lb/in2 were used for cell lysis. DitQ was assayed at concentrations of 0.46 to 0.77 µM, and DitU was assayed at concentrations of 0.61 to 0.70 µM.
In vitro P450 assay. Crude lysates of E. coli expressing DitQ or DitU were collected and quantified as described previously for substrate binding assays (39). Ferredoxin DitA3 from P. abietaniphila BKME-9 and ferredoxin reductase BphG from Comamonas testosteroni were each purified to homogeneity, as previously described (6, 15). Vials containing both DitA3 and BphG were sparged with argon for approximately 1 min prior to the activity assay. BphG (1.8 µM), DitA3 (3.6 µM), crude lysate of E. coli expressing DitQ or DitU (1.0 µM), NADH (350 µM), and 100 µM DhA, AbA, or PaA were combined and incubated for 5 min at room temperature or for 30 min at 30°C. The controls included an acidified reaction mixture or crude lysate from isopropyl-β-D-thiogalactopyranoside (IPTG)-induced E. coli containing pEX18Ap.
|
|
|---|
10% of each proteome was unique to DhA or AbA, indicating that these compounds had distinct physiological effects.
![]() View larger version (14K): [in a new window] |
FIG. 1. Global analysis of LB400 cytosolic proteomes: Venn diagram representation of the protein spots whose normalized intensity was greater than 0.002. The numbers in brackets indicate the total numbers of protein spots detected in the corresponding average gels using Progenesis software.
|
|
View this table: [in a new window] |
TABLE 3. Proteins involved in abietane diterpenoid catabolism identified by MASCOT-based analysis of matrix-assisted laser desorption ionization-time of flight spectra
|
Growth of mutant strains. To investigate the functions of the identified P450s in abietane diterpenoid catabolism, two mutant strains were generated, DitQKO and DitUKO, in which ditQ and ditU, respectively, were disrupted. The mutants had distinct growth phenotypes. The disruption of ditQ completely abolished the ability of LB400 to grow on DhA, indicating the essential role of this gene in DhA catabolism (Fig. 2). This mutation also increased the lag phase prior to growth on AbA and PaA by approximately 100 h and increased the doubling time on PaA 2.0-fold. By contrast, the disruption of ditU abolished the ability of LB400 to grow on AbA, indicating the essential role of this gene in AbA catabolism. This mutation also increased the lag phase prior to growth on PaA by approximately 100 h and increased the doubling time on PaA 1.5-fold. Growth on the catabolic intermediate, 7-oxo-DhA, was not affected by disruption of either ditQ or ditU, and neither mutation had a major effect on the growth yield with any substrate, except when growth was completely abolished.
![]() View larger version (26K): [in a new window] |
FIG. 2. Growth characteristics of LB400 (WT) and two mutant strains, DitUKO (DitU) and DitQKO (DitQ), on four abietane diterpenoids. The initial inoculum for each culture was 2 x 106 cells/ml grown to mid-log phase on succinate. N indicates no growth. The error bars indicate standard errors.
|
The disruption of ditQ did not affect the ability of LB400 to degrade AbA (Fig. 3); however, DitUKO cells removed only 34% of AbA within 72 h. This further confirmed that ditU, but not ditQ, is required for the catabolism of AbA. Since 7-oxo-DhA is a minor contaminant of the AbA reagent, trace amounts of 7-oxo-DhA were detected in all samples with AbA. The LB400 and DitQKO cells incubated with AbA accumulated additional 7-oxo-DhA, whereas with DitUKO the initial concentration of this compound did not change. This suggests that 7-oxo-DhA is a metabolite that is normally formed during AbA catabolism by a process requiring DitU. Additionally, small amounts of 7-oxo-PaA accumulated in incubations of all three strains with AbA. Both these metabolites were previously observed during diterpenoid catabolism and were identified on the basis of their mass spectra (38).
![]() View larger version (19K): [in a new window] |
FIG. 3. Metabolite analysis of cell suspensions of LB400, DitQKO, and DitUKO incubated with AbA, DhA, and PaA. The scale for the filled symbols is on the left y axis, and the scale for the open symbols and the multiplication signs is on the right y axis. Symbols: , AbA; and , DhA; , PaA; , 7-oxo-DhA; x, 7-oxo-PaA. The data for wild-type strain LB400 are from reference 38. The data are from single experiments that were done in triplicate and in which consistent patterns of substrate removal and metabolite formation were observed. The final values were reproducible, but some differences in rates precluded averaging the data from independent experiments.
|
During 72 h of incubation with PaA, LB400 and DitQKO removed most of the PaA, whereas DitUKO removed only a minor fraction (Fig. 3). With a longer incubation time (144 h) (not shown), LB400 completely removed the PaA, whereas DitQKO and DitUKO did not. Since DhA is a contaminant of the PaA reagent, small amounts of DhA were initially present in all treatments with PaA. All strains accumulated additional DhA as well as 7-oxo-DhA and 7-oxo-PaA. All the strains tested completely removed 7-oxo-DhA within 24 h (data not shown), clearly indicating that neither DitQ nor DitU is essential for catabolism of 7-oxo-DhA.
Binding assays. To confirm that ditQ and ditU encode functional P450s, carbon monoxide binding assays were conducted. Both DitQ and DitU, produced in a crude lysate of E. coli, bound carbon monoxide and yielded a Soret maximum absorbance between 447 and 450 nm with little absorbance at 420 nm (not shown). This indicates that both DitQ and DitU are members of the P450 superfamily and are expressed in E. coli in a native conformation.
To investigate the range of compounds that bind to DitQ and DitU, substrate-binding assays were conducted. Addition of DhA to a solution of DitQ induced a type I difference spectrum typical of substrate binding with a maximum at 388 nm and a minimum at 421 nm (Fig. 4A). Titration with DhA yielded a dissociation constant (Kd) of 0.98 ± 0.01 µM (Tris-HCl buffer, pH 7.4). PaA also induced a type I-like curve for DitQ, indicating that PaA is also a substrate for this P450 (Fig. 4B). However, an isosbestic point at 407 nm was not observed, and therefore the Kd could not be determined. AbA induced changes in the spectrum of DitQ, suggesting that it bound to the enzyme, perturbing the heme environment. However, the binding equation could not be fitted to the data, and therefore the results were inconclusive. 7-Oxo-DhA did not alter the spectrum of DitQ at concentrations up to 25 µM, indicating that it is not a substrate for DitQ. The same assay was used to investigate binding of abietane diterpenoids to DitU; however, none of the compounds yielded definite binding spectra.
![]() View larger version (15K): [in a new window] |
FIG. 4. Binding spectra of DitQ and DhA or PaA. (A) DhA binding to DitQ. The data points indicate the difference in absorbance between 387 and 421 nm caused by increasing DhA concentrations. The curve represents a best fit of the binding equation (5) to the data, in which Kd is 0.98 ± 0.01 µM and the maximum change in absorbance is 1.16 x 10–1 ± 6.55 x 10–3. (Inset) UV-visible difference spectra for DitQ with increasing concentrations of DhA. (B) PaA binding to DitQ: UV-visible difference spectra of DitQ with increasing concentrations of PaA. Because an isosbestic point was not observed, PaA data could not be fit to the binding equation. The arrows indicate increases in the amplitude of the maximum or minimum absorbance caused by increasing the concentration of DhA or PaA.
|
|
|
|---|
DitQ and DitU. The genome of LB400 encodes six P450s (4). DitQ and DitU are the only P450s encoded in the dit cluster and share 61% amino acid sequence identity. By contrast, their levels of identity with the other four P450s are less than 25%. Our finding that DitQ is essential for LB400 to grow on DhA (Fig. 2) and to transform DhA (Fig. 3) differs somewhat from the findings of two previous studies in which disruption of ditQ homologs impaired but did not abolish growth on DhA of either P. abietaniphila BKME-9 (39) or P. diterpeniphila A19-6a (27). It is possible that these strains have additional P450s, possibly DitU homologs, that partially complement DitQ. In LB400, DitU is not expressed during growth on DhA, which may prevent complementation of DitQ.
While our proteomic analysis of LB400 indicated that both DitQ and DitU were expressed on AbA (Table 3), only DitU was required for growth on AbA (Fig. 2) and substantial removal of AbA (Fig. 3). Expression of ditQ on AbA appears to be an unnecessary consequence of its regulatory system. This pattern of expression is consistent with the results of a study with BKME-9, in which a reporter construct demonstrated that ditQ is induced by AbA, DhA, and PaA (39).
Binding properties and catalytic activities of DitQ and DitU. The present study provides the first experimental evidence that DitQ transforms DhA to 7-hydroxy-DhA, which is the first catalytic activity demonstrated for a CYP226A subfamily P450. 7-Hydroxy-DhA is a metabolite in the bacterial (3) and fungal (17) degradation of DhA, and we previously proposed that DitQBKME-9 transforms DhA to 7-hydroxy-DhA (39). Although DitQLB400 shares 71% amino acid identity with its ortholog DitQBKME-9, the two proteins have distinct substrate-binding properties. These P450s bind DhA with comparable affinities (the Kd values are 0.98 ± 0.01 µM [Fig. 4] and 0.43 ± 0.03 µM [39], respectively), but only DitQLB400 showed PaA binding. DitQLB400 failed to transform PaA in our assay, but we cannot rule out the possibility of in vivo transformation, because the in vitro assay may have been limited by suboptimal conditions, including the use of a nonnative electron transport system. Similarly, we cannot rule out the possibility that DitQLB400 binds AbA, since AbA perturbed the enzyme's spectrum.
The proteomic (Table 3) and gene disruption (Fig. 2 and 3) analyses indicated that DitU is involved in the catabolism of AbA. However, the DitU substrate-binding assays and in vitro activity assays were inconclusive. Despite the lack of clear binding spectra, it is still possible that AbA or one of the other compounds tested binds to DitU, as substrates do not always yield type I binding spectra for P450s. Thus, neither deoxycorticosterone (36) nor morpholine (35) induces binding spectra in the P450s that transform them. As noted above, a suboptimal assay also may explain our failure to detect in vitro DitU activity. Alternatively, DitU may transform a catabolite of AbA.
Initial steps of diterpenoid catabolism. Several lines of evidence demonstrate that both DitU and DitQ are involved in the conversion by LB400 of abietane diterpenoids to the common intermediate 7-oxo-DhA (Fig. 5), the substrate for the ring-hydroxylating dioxygenase, DitA (23). The results unambiguously demonstrate that DitQLB400 binds DhA and transforms it to 7-hydroxy-DhA (Fig. 2 to 4). The latter compound is presumably oxidized to 7-oxo-DhA by an unidentified dehydrogenase. This pathway for DhA is consistent with studies of BKME-9 (22, 39).
![]() View larger version (22K): [in a new window] |
FIG. 5. Proposed convergent pathway for abietane diterpenoid degradation by LB400, indicating proposed transformations catalyzed by oxygenases.
|
Our data strongly suggest two distinct routes for PaA catabolism in LB400 (Fig. 5). The first route involves aromatization of PaA to DhA and is consistent with the formation of DhA observed in cell suspensions incubated with PaA (Fig. 3). This aromatization of ring C of PaA is analogous to that proposed above for 7-oxo-PaA and might be catalyzed by the same enzyme. The DhA formed is presumably degraded as described above. The second proposed route involves hydroxylation of PaA to 7-hydoxy-PaA, which is further degraded via 7-oxo-PaA and subsequent intermediates described above. The second route is consistent with formation of 7-oxo-PaA in cell suspensions incubated with PaA (Fig. 3). It thus appears that 7-oxo-PaA is a point of convergence for AbA catabolism and PaA catabolism.
The involvement of DitQ and DitU in PaA catabolism has not been fully resolved. The partially impaired growth of DitQKO and DitUKO on PaA (Fig. 2) indicates that both P450s are likely involved in PaA catabolism. The DhA formed from PaA is presumably hydroxylated by DitQ. This role for DitQ is supported by the accumulation of DhA when DitQKO was incubated with PaA, but we cannot exclude the possibility that DitU also catalyzes this hydroxylation. The dramatic loss of PaA removal activity in DitUKO strongly suggests that DitU is primarily responsible for hydroxylation of PaA, but production of traces of 7-oxo-PaA by DitUKO suggests that DitQ may also have some capacity for this hydroxylation, consistent with binding of PaA to DitQ (Fig. 4B). Overall, DitU appears to play a more significant role than DitQ in PaA catabolism. However, further studies are required to define the roles of the P450s and other enzymes in PaA catabolism.
Electron transport system. The present study supports and expands our previous suggestion (38) that a multicomponent electron transport system is shared by three dit-encoded oxygenases, the P450s DitQ and DitU and the ring-hydroxylating dioxygenase DitA. BxeC0579 is the only ferredoxin reductase gene in the dit cluster of LB400 and is the only such gene up-regulated during growth on DhA (38). The dit cluster encodes two ferredoxins (38). The first ferredoxin, encoded by BxeC0601, is a typical plant-type 2Fe-2S ferredoxin. The second ferredoxin, encoded by ditA3, shares 60% amino acid sequence identity with the 3Fe-4S ferredoxin DitA3BKME-9 (6). DitA3LB400 and DitA3BKME-9 are 100% identical over regions containing Fe-S cluster ligands. A BKME-9 ditA3 disruption mutant was unable to grow on DhA but did transform DhA to 7-oxo-DhA (22), indicating that in BKME-9, DitA3 is essential for DitA activity but not for DitQ activity. The current study demonstrates that DitA3BKME-9 can function with DitQLB400 in vitro, suggesting that DitA3LB400 may function with DitQLB400 in vivo. In LB400, it is possible that the 2Fe-2S ferredoxin encoded by BxeC0601 also functions with DitQ. BxeC0601 is located two open reading frames downstream of ditQ and is up-regulated during growth on DhA. If BKME-9 also has such a 2Fe-2S ferredoxin, this might explain why DitA3 is not essential for DitQ activity in this organism. Overall, there appears to be an overlapping system of electron transfer involving one ferredoxin reductase, two ferredoxins (3Fe-4S and 2Fe-2S), and the three oxygenases. This organization is reminiscent of the organization in Sphingomonas wittichii RW1, in which two ferredoxins transfer electrons to a single dioxygenase (2), and the organization in Ralstonia sp. strain U2, in which a single reductase and ferredoxin transfer electrons to two oxygenases (43). To determine the compatibilities of the various LB400 proteins, further study with purified electron transfer and catalytic components is needed.
CYP226 family. Using available databases, we identified seven genes putatively encoding P450s belonging to the CYP226A subfamily (28). These P450s all share greater than 44% amino acid sequence identity. In addition to DitQLB400 (CYP226A1) and DitULB400 (CYP226A2), two other proteins are from bacteria known to grow on abietane diterpenoids as a sole source of carbon and energy: DitQBKME-9 and TdtD (CYP226A3) from P. diterpeniphila A19-6a (27). Another two proteins are encoded by a putative dit cluster (38) in the recently sequenced genome of Pseudomonas aeruginosa 2192 (Broad Institute of Harvard and Massachusetts Institute of Technology; http://www.broad.mit.edu) and appear to be orthologs of DitQLB400 and DitULB400. Other complete genomes with dit clusters were not found. The seventh CYP226A member, having 44 to 48% identity with the other members, is encoded by the draft genome sequence of Caulobacter sp. strain K31 (U.S. Department of Energy Joint Genome Institute; http://www.jgi.doe.gov/). CYP226A genes were also identified in the Sargasso Sea metagenome (41). Demonstration that divergent members of the CYP226A P450 subfamily are involved in diterpenoid catabolism would allow prediction of other abietane diterpenoid-degrading strains based on the presence of CYP226A homologs.
This research was supported by a Discovery Grant from the Natural Sciences and Engineering Council of Canada.
Published ahead of print on 21 December 2007. ![]()
Present address: Department of Microbiology and Molecular Genetics, Oklahoma State University, 307 Life Sciences East, Stillwater, OK 74078. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»